Epizyme presents preclinical research on CARM1 and PRMT6
21 April 2015 | By Victoria White
Epizyme has presented data on two epigenetic targets, CARM1 and PRMT6, in its pioneering therapeutic pipeline at the AACR Annual Meeting 2015...
List view / Grid view
News
Trial shows benefit of ‘BRCA-targeting’ drug, olaparib, in prostate cancer
21 April 2015 | By Victoria White
Men with prostate cancer benefit from treatment with the pioneering drug olaparib according to the results of a major trial presented today...
MaxCyte and Johns Hopkins University announce strategic collaboration to advance CAR T-cell therapies
21 April 2015 | By Victoria White
MaxCyte and Johns Hopkins University to collaborate to develop unique CAR T-cell therapies which harness patients’ own immune systems to combat cancers...
Transgene presents preclinical data for TG4010 and TG3003 at AACR 2015
21 April 2015 | By Victoria White
Transgene has announced that new preclinical data for two of its programmes – TG4010 and TG3003 – were presented at the Annual Meeting of the AACR...
Cardio3 BioSciences announces infusion of first patient in NKG2D Phase I trial
21 April 2015 | By Victoria White
The first patient enrolled in a Phase I clinical trial evaluating the safety and feasibility of NKG2D CAR T-cell therapy has been infused...
MRC Technology appoints Andrew Mercieca as Finance Director
21 April 2015 | By Victoria White
MRC Technology, an independent life science medical research charity, has appointed Andrew Mercieca as its Finance Director from 1 April 2015...
Results announced from a preclinical study of AV-380 for the treatment of cancer associated cachexia
20 April 2015 | By Victoria White
Results from a preclinical study of AV-380, a GDF15 inhibitory antibody for the treatment of cancer associated cachexia, have been presented at AACR 2015...
New research collaboration to study RNA-binding proteins for the creation of new therapeutic target candidates
20 April 2015 | By Victoria White
Takeda, Keio University and Niigata University are to collaborate to research disease-related RNA-binding proteins, possibly leading to new treatments...
Positive preclinical data on IRAK4 inhibitor compounds presented at AACR 2015
20 April 2015 | By Victoria White
Preclinical data demonstrating single agent and combination activity of two of TG Therapeutics’ IRAK4 inhibitor compounds has been presented AACR 2015...
DelMar presents positive preclinical data on VAL-083 for treatment of non-small cell lung cancer
20 April 2015 | By Victoria White
DelMar Pharmaceuticals presented positive preclinical data on its lead product candidate VAL-083 for treatment of platinum drug-resistant NSCLC at AACR2015...
Blueprint Medicines presents preclinical data demonstrating significant anti-tumour activity of BLU-285 in treatment-resistant GIST
20 April 2015 | By Victoria White
New preclinical data demonstrates that BLU-285 has significant anti-tumour activity in treatment-resistant models of gastrointestinal stromal tumours (GIST)...
Oxford Global’s interview with Araz Raoof of Janssen Pharmaceuticals and Juan-Miguel Jimenez of Vertex Pharmaceuticals in the lead up to the 16th Annual Drug Discovery Summit
20 April 2015 | By Oxford Global
Oxford Global is proud to present its 16th Annual Drug Discovery Summit and the co-located 3rd Annual Discovery Chemistry & Drug Design Congress taking place in Berlin on the 8th and 9th of June 2015...
Peloton Therapeutics presents promising data on PT2385, the first Inhibitor of HIF-2a for renal cell carcinoma
20 April 2015 | By Victoria White
Peloton presented promising preclinical data on PT2385, the first Inhibitor of HIF-2a for renal cell carcinoma, at AACR 2015...
Consortium awarded €8.4 million for development of thermo stable and cold-chain independent virosome-based vaccines
20 April 2015 | By Victoria White
Mymetics is leading a consortium to development thermo stable and cold-chain independent nano-pharmaceutical virosome-based vaccine candidates.
Novogen and the Feinstein Institute collaborate to develop effective treatments for brain cancers
17 April 2015 | By Victoria White
Novogen and the Feinstein Institute for Medical Research are to collaborate to develop effective treatments for brain cancers...